| Dr Mayank Singhal, MD | |
|
1638 Owen Dr, Fayetteville, NC 28304-3424 | |
| (910) 615-5680 | |
| (910) 615-5681 |
| Full Name | Dr Mayank Singhal |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 14 Years |
| Location | 1638 Owen Dr, Fayetteville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265717474 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 2014-01531 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cape Fear Valley Medical Center | Fayetteville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cumberland County Hospital System Inc | 1850204041 | 455 |
News Archive
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced nationwide availability of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay beginning in the first quarter of 2014.
A small study, previously posted to the medRiv preprint server in early March, was recently published in the journal Science Immunology. The now peer-reviewed research led by E. John Wherry of the University of Pennsylvania Perelman School of Medicine finds people previously exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produced a more robust immune response after receiving the first — but not the second mRNA vaccine.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
Dr Jane O'Connell, Australia's first endorsed nurse practitioner specialising in emergency care, is leading the way in re-defining the role specialty nurse practitioners play in the health system.
The state's regulators didn't raise concerns about premium increases for the 10 plans in California's online marketplace. In addition, enrollment efforts make news in Missouri and Minnesota.
› Verified 6 days ago
| Entity Name | Cumberland County Hospital System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881946242 PECOS PAC ID: 1850204041 Enrollment ID: O20031112000693 |
News Archive
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced nationwide availability of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay beginning in the first quarter of 2014.
A small study, previously posted to the medRiv preprint server in early March, was recently published in the journal Science Immunology. The now peer-reviewed research led by E. John Wherry of the University of Pennsylvania Perelman School of Medicine finds people previously exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produced a more robust immune response after receiving the first — but not the second mRNA vaccine.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
Dr Jane O'Connell, Australia's first endorsed nurse practitioner specialising in emergency care, is leading the way in re-defining the role specialty nurse practitioners play in the health system.
The state's regulators didn't raise concerns about premium increases for the 10 plans in California's online marketplace. In addition, enrollment efforts make news in Missouri and Minnesota.
› Verified 6 days ago
| Entity Name | Apogee Medical Group North Carolina |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043518228 PECOS PAC ID: 7719162254 Enrollment ID: O20110427000840 |
News Archive
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced nationwide availability of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay beginning in the first quarter of 2014.
A small study, previously posted to the medRiv preprint server in early March, was recently published in the journal Science Immunology. The now peer-reviewed research led by E. John Wherry of the University of Pennsylvania Perelman School of Medicine finds people previously exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produced a more robust immune response after receiving the first — but not the second mRNA vaccine.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
Dr Jane O'Connell, Australia's first endorsed nurse practitioner specialising in emergency care, is leading the way in re-defining the role specialty nurse practitioners play in the health system.
The state's regulators didn't raise concerns about premium increases for the 10 plans in California's online marketplace. In addition, enrollment efforts make news in Missouri and Minnesota.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mayank Singhal, MD 1638 Owen Dr, Fayetteville, NC 28304-3424 Ph: (910) 615-5680 | Dr Mayank Singhal, MD 1638 Owen Dr, Fayetteville, NC 28304-3424 Ph: (910) 615-5680 |
News Archive
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced nationwide availability of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay beginning in the first quarter of 2014.
A small study, previously posted to the medRiv preprint server in early March, was recently published in the journal Science Immunology. The now peer-reviewed research led by E. John Wherry of the University of Pennsylvania Perelman School of Medicine finds people previously exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produced a more robust immune response after receiving the first — but not the second mRNA vaccine.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.
Dr Jane O'Connell, Australia's first endorsed nurse practitioner specialising in emergency care, is leading the way in re-defining the role specialty nurse practitioners play in the health system.
The state's regulators didn't raise concerns about premium increases for the 10 plans in California's online marketplace. In addition, enrollment efforts make news in Missouri and Minnesota.
› Verified 6 days ago
Prutha Patel, Hospitalist Medicare: Medicare Enrolled Practice Location: 1638 Owen Drive, Fayetteville, NC 28304 Phone: 910-615-5095 | |
Dr. Leon E Dantzler, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Robeson St, Suite 300, Fayetteville, NC 28301 Phone: 910-609-1617 Fax: 910-609-1618 | |
Samuel Swartz, PA Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-615-4000 | |
Dr. Oliver M. Olea, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-615-5610 Fax: 915-615-5080 | |
Victor Long, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-615-5095 |